drugset / Trial / NCT00757679

Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

NCT00757679

Phase 2 Completed 153 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of the antinociceptive effect of 7 weeks of treatment with milnacipran, compared to placebo, in fibromyalgia out-patients

Timeline

Start
2006-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified

Indications